Filed: 2/14/2024ACC: 0001826434-24-000002
📋 What this filing means
TRI LOCUM PARTNERS LP filed this quarterly 13F‑HR report disclosing 24 equity positions with a total reported market value of $218.76M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
24
Positions
$218.76M
Total AUM (reported)
6.57M
Total Shares
Allocation by class
COM$125.90M57.6%
SPONSORED ADR$37.56M17.2%
SPONSORED ADS$30.71M14.0%
COMMON STOCK$13.27M6.1%
COM NEW$5.54M2.5%
SHS$2.90M1.3%
CLASS A ORD$2.87M1.3%
Portfolio Concentration
Top 3$59.78M27.3%
4–10$85.76M39.2%
11–25$73.22M33.5%
Top 3 weight
27.3%
Top 10 weight
66.5%
Voting Authority Distribution
Total shares with voting rights: 6.57M
Sole
Full voting authority
6.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole24
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings24
Rows:
ABBVIE INC
SOLEShares167.81K
TypeSH
Market value$26.01M
11.89%
Sole
167.81K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares1.79M
TypeSH
Market value$18.73M
8.56%
Sole
1.79M
Shared
0.00
None
0.00
KENVUE INC
SOLEShares698.80K
TypeSH
Market value$15.05M
6.88%
Sole
698.80K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares16.01K
TypeSH
Market value$14.06M
6.43%
Sole
16.01K
Shared
0.00
None
0.00
GE HEALTHCARE TECHNOLOGIES I
SOLEShares171.68K
TypeSH
Market value$13.27M
6.07%
Sole
171.68K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares99.55K
TypeSH
Market value$12.54M
5.73%
Sole
99.55K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares839.93K
TypeSH
Market value$11.86M
5.42%
Sole
839.93K
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares45.81K
TypeSH
Market value$11.86M
5.42%
Sole
45.81K
Shared
0.00
None
0.00
CATALENT INC
SOLEShares261.80K
TypeSH
Market value$11.76M
5.38%
Sole
261.80K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares130.74K
TypeSH
Market value$10.41M
4.76%
Sole
130.74K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares225.56K
TypeSH
Market value$10.39M
4.75%
Sole
225.56K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares24.18K
TypeSH
Market value$9.20M
4.21%
Sole
24.18K
Shared
0.00
None
0.00
NATERA INC
SOLEShares141.85K
TypeSH
Market value$8.89M
4.06%
Sole
141.85K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares102.22K
TypeSH
Market value$6.15M
2.81%
Sole
102.22K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares25.52K
TypeSH
Market value$5.91M
2.70%
Sole
25.52K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares293.11K
TypeSH
Market value$5.83M
2.66%
Sole
293.11K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares248.76K
TypeSH
Market value$5.54M
2.53%
Sole
248.76K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares542.95K
TypeSH
Market value$4.17M
1.91%
Sole
542.95K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares58.79K
TypeSH
Market value$3.96M
1.81%
Sole
58.79K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares207.15K
TypeSH
Market value$3.89M
1.78%
Sole
207.15K
Shared
0.00
None
0.00
ARCTURUS THERAPEUTICS HLDGS
SOLEShares110.47K
TypeSH
Market value$3.48M
1.59%
Sole
110.47K
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares275.48K
TypeSH
Market value$2.90M
1.33%
Sole
275.48K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares47.60K
TypeSH
Market value$2.87M
1.31%
Sole
47.60K
Shared
0.00
None
0.00
FEMASYS INC
SOLEShares36.15K
TypeSH
Market value$35.2K
0.02%
Sole
36.15K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABBVIE INCSOLE | COM | 167.81K | SH | $26.01M 11.89% | 167.81K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 1.79M | SH | $18.73M 8.56% | 1.79M | 0.00 | 0.00 |
KENVUE INCSOLE | COM | 698.80K | SH | $15.05M 6.88% | 698.80K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 16.01K | SH | $14.06M 6.43% | 16.01K | 0.00 | 0.00 |
GE HEALTHCARE TECHNOLOGIES ISOLE | COMMON STOCK | 171.68K | SH | $13.27M 6.07% | 171.68K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 99.55K | SH | $12.54M 5.73% | 99.55K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | SPONSORED ADR | 839.93K | SH | $11.86M 5.42% | 839.93K | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 45.81K | SH | $11.86M 5.42% | 45.81K | 0.00 | 0.00 |
CATALENT INCSOLE | COM | 261.80K | SH | $11.76M 5.38% | 261.80K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 130.74K | SH | $10.41M 4.76% | 130.74K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 225.56K | SH | $10.39M 4.75% | 225.56K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 24.18K | SH | $9.20M 4.21% | 24.18K | 0.00 | 0.00 |
NATERA INCSOLE | COM | 141.85K | SH | $8.89M 4.06% | 141.85K | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 102.22K | SH | $6.15M 2.81% | 102.22K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 25.52K | SH | $5.91M 2.70% | 25.52K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 293.11K | SH | $5.83M 2.66% | 293.11K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 248.76K | SH | $5.54M 2.53% | 248.76K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 542.95K | SH | $4.17M 1.91% | 542.95K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 58.79K | SH | $3.96M 1.81% | 58.79K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 207.15K | SH | $3.89M 1.78% | 207.15K | 0.00 | 0.00 |
ARCTURUS THERAPEUTICS HLDGSSOLE | COM | 110.47K | SH | $3.48M 1.59% | 110.47K | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 275.48K | SH | $2.90M 1.33% | 275.48K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 47.60K | SH | $2.87M 1.31% | 47.60K | 0.00 | 0.00 |
FEMASYS INCSOLE | COM | 36.15K | SH | $35.2K 0.02% | 36.15K | 0.00 | 0.00 |